Seroincidence of Enteric Fever, Juba, South Sudan
Kristen Aiemjoy
, John Rumunu, Juma John Hassen, Kirsten E. Wiens, Denise Garrett, Polina Kamenskaya, Jason B. Harris, Andrew S. Azman, Peter Teunis, Jessica C. Seidman, Joseph F. Wamala, Jason R. Andrews, and Richelle C. Charles
Author affiliations: University of California Davis School of Medicine, Davis, California, USA (K. Aiemjoy); Republic of South Sudan Ministry of Health, Juba, South Sudan (J. Rumunu); World Health Organization, Juba (J.J. Hassen, J.F. Wamala); Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA (K.E. Wiens, A.S. Azman); Sabin Vaccine Institute, Washington, DC, USA (D. Garrett, J.C. Seidman); Massachusetts General Hospital, Boston, Massachusetts, USA (P. Kamenskaya, J.B. Harris, R.C. Charles); Emory University, Atlanta, Georgia, USA (P. Teunis); Stanford University School of Medicine, Stanford, California, USA (J.R. Andrews)
Main Article
Figure 2
Figure 2. Estimated seroincidence of typhoidal Salmonella by age, Juba, South Sudan, 2020. A) Seroincidence per age group. Error bars indicate 95% CIs. B, C) Individually predicted incidence estimates (points) and smoothed cumulative incidence (lines) over 2-year (B) and 4-year (C) periods, by age. Gray shading indicates 95% CIs.
Main Article
Page created: October 13, 2022
Page updated: October 24, 2022
Page reviewed: October 24, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.